InterviewsMarch 2, 2021 Investing in Psychedelic Medicine and Sustainable Solutions for Mental Health and Well Being
PressFebruary 23, 2021 PharmaTher Announces Research Collaboration for Microneedle Delivery of Psychedelic Pharmaceuticals
PressFebruary 22, 2021 Awakn Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Trial
Psychedelic NewsFebruary 19, 2021 Atai Life Sciences Partners with Bionomics on MDMA Combination Therapies
Market ResearchFebruary 12, 2021 How The Pandemic Has Highlighted the Need for Mental Health Alternatives
